Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 May;2(3):365–368. doi: 10.1128/cdli.2.3.365-368.1995

Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

C M Verduin 1, C Hol 1, E Van Dijke 1, J A Faber 1, M Jansze 1, J Verhoef 1, H Van Dijk 1
PMCID: PMC170161  PMID: 7664184

Abstract

Recently, we showed that complement resistance is an important virulence factor of Moraxella (Branhamella) catarrhalis. Our study used a serum bactericidal assay to determine complement resistance in M. catarrhalis. Although the serum bactericidal assay is considered the "gold standard" for determining complement resistance, it is laborious and time-consuming and therefore not well suited for large-scale studies. Using a large number (n = 324) of M. catarrhalis isolates obtained from the sputa of patients with lower respiratory tract infections (n = 200) and young carriers (n = 124), we assessed the value of a simple "culture-and-spot" test as an alternative to the serum bactericidal assay. For both groups of isolates, the degree of concordance between the two tests used was very significant (P < 0.0001). The agreement between the two assays was estimated to be "excellent beyond chance" (as determined by Cohen's kappa test). The culture-and-spot assay is a valuable alternative to the serum bactericidal assay, not only for screening purposes as shown here but also for studying the mechanism of complement resistance in M. catarrhalis at the molecular level.

Full Text

The Full Text of this article is available as a PDF (310.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aumont P., Enard C., Expert D., Pieddeloup C., Tancrède C., Andremont A. Production of haemolysin, aerobactin and enterobactin by strains of Escherichia coli causing bacteraemia in cancer patients, and their resistance to human serum. Res Microbiol. 1989 Jan;140(1):21–26. doi: 10.1016/0923-2508(89)90055-7. [DOI] [PubMed] [Google Scholar]
  2. Bliska J. B., Falkow S. Bacterial resistance to complement killing mediated by the Ail protein of Yersinia enterocolitica. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3561–3565. doi: 10.1073/pnas.89.8.3561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyle F. M., Georghiou P. R., Tilse M. H., McCormack J. G. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust. 1991 May 6;154(9):592–596. doi: 10.5694/j.1326-5377.1991.tb121219.x. [DOI] [PubMed] [Google Scholar]
  4. Brorson J. E., Axelsson A., Holm S. E. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. doi: 10.3109/inf.1976.8.issue-3.05. [DOI] [PubMed] [Google Scholar]
  5. Catlin B. W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990 Oct;3(4):293–320. doi: 10.1128/cmr.3.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chapman A. J., Jr, Musher D. M., Jonsson S., Clarridge J. E., Wallace R. J., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. doi: 10.1093/infdis/151.5.878. [DOI] [PubMed] [Google Scholar]
  7. Criado M. T., del Río M. C., Ferreirós C. M., Pintor M., Sáinz V., Carballo J. Iron and outer membrane proteins in the susceptibility of Neisseria meningitidis to human serum. FEMS Microbiol Lett. 1990 Jul;58(2):145–150. doi: 10.1111/j.1574-6968.1990.tb13968.x. [DOI] [PubMed] [Google Scholar]
  8. Ejlertsen T. Pharyngeal carriage of Moraxella (Branhamella) catarrhalis in healthy adults. Eur J Clin Microbiol Infect Dis. 1991 Feb;10(2):89–89. doi: 10.1007/BF01964414. [DOI] [PubMed] [Google Scholar]
  9. Fierer J., Finley F., Braude A. I. A plaque assay on agar for detection of gram-negative bacilli sensitive to complement. J Immunol. 1972 Nov;109(5):1156–1158. [PubMed] [Google Scholar]
  10. Hager H., Verghese A., Alvarez S., Berk S. L. Branhamella catarrhalis respiratory infections. Rev Infect Dis. 1987 Nov-Dec;9(6):1140–1149. doi: 10.1093/clinids/9.6.1140. [DOI] [PubMed] [Google Scholar]
  11. Hamadeh R. M., Jarvis G. A., Galili U., Mandrell R. E., Zhou P., Griffiss J. M. Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest. 1992 Apr;89(4):1223–1235. doi: 10.1172/JCI115706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hol C., Verduin C. M., van Dijke E., Verhoef J., van Dijk H. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet. 1993 May 15;341(8855):1281–1281. doi: 10.1016/0140-6736(93)91185-o. [DOI] [PubMed] [Google Scholar]
  13. Joiner K. A., Warren K. A., Brown E. J., Swanson J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol. 1983 Sep;131(3):1443–1451. [PubMed] [Google Scholar]
  14. Jordan K. L., Berk S. H., Berk S. L. A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis. Am J Med. 1990 May 14;88(5A):28S–32S. doi: 10.1016/0002-9343(90)90258-f. [DOI] [PubMed] [Google Scholar]
  15. Namavar F., Verweij-Van Vught M. A., Maclaren D. M. A study of the candidate virulence factors of Bacteroides fragilis. J Gen Microbiol. 1991 Jun;137(6):1431–1435. doi: 10.1099/00221287-137-6-1431. [DOI] [PubMed] [Google Scholar]
  16. Patterson T. F., Patterson J. E., Masecar B. L., Barden G. E., Hierholzer W. J., Jr, Zervos M. J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis. 1988 May;157(5):996–1001. doi: 10.1093/infdis/157.5.996. [DOI] [PubMed] [Google Scholar]
  17. Porat R., Mosseri R., Kaplan E., Johns M. A., Shibolet S. Distribution of polysaccharide side chains of lipopolysaccharide determine resistance of Escherichia coli to the bactericidal activity of serum. J Infect Dis. 1992 May;165(5):953–956. doi: 10.1093/infdis/165.5.953. [DOI] [PubMed] [Google Scholar]
  18. Richards S. J., Greening A. P., Enright M. C., Morgan M. G., McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax. 1993 Jan;48(1):91–92. doi: 10.1136/thx.48.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sarubbi F. A., Myers J. W., Williams J. J., Shell C. G. Respiratory infections caused by Branhamella catarrhalis. Selected epidemiologic features. Am J Med. 1990 May 14;88(5A):9S–14S. doi: 10.1016/0002-9343(90)90254-b. [DOI] [PubMed] [Google Scholar]
  20. Soto-Hernandez J. L., Holtsclaw-Berk S., Harvill L. M., Berk S. L. Phenotypic characteristics of Branhamella catarrhalis strains. J Clin Microbiol. 1989 May;27(5):903–908. doi: 10.1128/jcm.27.5.903-908.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vaneechoutte M., Verschraegen G., Claeys G., Weise B., Van den Abeele A. M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol. 1990 Dec;28(12):2674–2680. doi: 10.1128/jcm.28.12.2674-2680.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Verduin C. M., Jansze M., Hol C., Mollnes T. E., Verhoef J., van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun. 1994 Feb;62(2):589–595. doi: 10.1128/iai.62.2.589-595.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weiser J. N., Gotschlich E. C. Outer membrane protein A (OmpA) contributes to serum resistance and pathogenicity of Escherichia coli K-1. Infect Immun. 1991 Jul;59(7):2252–2258. doi: 10.1128/iai.59.7.2252-2258.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Wetzler L. M., Barry K., Blake M. S., Gotschlich E. C. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect Immun. 1992 Jan;60(1):39–43. doi: 10.1128/iai.60.1.39-43.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES